For the Czech Republic and Slovakia market
Cipla announced a commercial collaboration with S&D Pharma in the Czech Republic and Slovakia. This collaboration will enable Cipla to focus on its core therapy areas, while S&D Pharma will be the key partner for generics.Under the collaboration, Cipla will be driving its respiratory product portfolio in both Czech Republic and Slovakia through a Cipla owned sales force team, managed by Cipla commercial head.
S&D Pharma will physically distribute all products, including respiratory products, and this portfolio will increase over the next few years.
Powered by Capital Market - Live News
